Samuel Sim, MD
Gastroenterology · Bristol, TNNPI 1275633844
Payments from drug & device makers
Across 523 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$926
- Nestle Healthcare Nutrition Inc.$792
- Bristol Myers Squibb$773
- plus $4K from 28 others
What the payments were for
- Travel & lodging$1851%
- Food & beverage$12,38896%
- Education$3943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 124 | $3,246 |
| Johnson & Johnson(2 entities) | 53 | $1,591 |
| Takeda Pharmaceuticals U.S.A., Inc. | 48 | $1,177 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 61 | $926 |
| Nestle Healthcare Nutrition Inc. | 42 | $792 |
| Bristol Myers Squibb | 32 | $773 |
| Intercept Pharmaceuticals, Inc. | 20 | $476 |
| Pfizer | 23 | $470 |
| Daiichi Sankyo Inc. | 17 | $393 |
| Gilead | 14 | $370 |
| Boston Scientific | 5 | $344 |
| Novo Nordisk | 7 | $320 |
| Lilly USA, LLC | 6 | $266 |
| Braintree Laboratories, Inc. | 15 | $234 |
| Sanofi | 5 | $203 |
| E.r. Squibb & Sons, L.L.C. | 2 | $185 |
| Shionogi Inc | 9 | $179 |
| Janssen Scientific Affairs, LLC | 2 | $153 |
| Madrigal Pharmaceuticals | 4 | $153 |
| Merck | 9 | $143 |
| UCB, Inc. | 2 | $106 |
| Ferring Pharmaceuticals Inc. | 5 | $76 |
| Aimmune Therapeutics, Inc. | 2 | $74 |
| Amgen | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Ironwood Pharmaceuticals, Inc | 3 | $37 |
| Boehringer Ingelheim | 1 | $29 |
| QOL Medical, LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Apollo Endosurgery US Inc | 1 | $20 |
| Pentax Of America, Inc. | 1 | $18 |
| Romark Laboratories, LC | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$458
- Skyrizi$341
- ZEPOSIA$336
- STELARA$271
- OCALIVA$223
- Entyvio$215
- GENERAL - BILIARY DEVICES$185
- Creon$125
- OMVOH$122
- Wegovy$119
- INJECTAFER$118
- EOHILIA$111
- LINX Reflux Management System$106
How this compares
$12,968 in reported general payments places this provider in the 75th percentile of 336 gastroenterology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Bristol
- Ziad YounesGermantown$15.6M
- Robert HerringNashville$3.2M
- Dawn Borromeo BeaulieuNashville$2.1M
- David SchwartzNashville$1.4M
- Kevin FinneganHermitage$1.4M
- Baldeep PablaNashville$1.2M
- Sara HorstNashville$1.2M
- Chakradhar ReddyJohnson City$884K
- Michael PoraykoNashville$870K
- Saras SharmaNashville$870K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.